Pilot Study of Erlotinib for the Treatment of Patients With de Novo Acute Myeloid Leukemia

Summary

This research study is looking for patients with newly diagnosed acute myeloid leukemia (AML), AML that has returned (relapsed), or it has not responded adequately to previous treatments. Treating certain patients with chemotherapy may not be to their benefit or may cause more harm than benefit. The purpose of this study is to find out what effects (good and bad) erlotinib has on patients and their AML.

Timeline

Start

2010-07

Primary completion

2012-03

Completion

2012-03

Drugs

Indications